Lupinus

Lady Bird Johnson Wildflower Center Predicts Big Spring Wildflower Showing

Retrieved on: 
Wednesday, February 21, 2024
Soil, Marketing, Plant, Phlox, Lady Bird Johnson, Lady Bird, Lupinus, Land management, Packera, Sunlight, Mortality, Ranunculus, Communication, Lindheimera

Austin, Texas, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Austin, TX– Experts at the Lady Bird Johnson Wildflower Center are predicting the 2024 wildflower season to be a banner year of blooms.

Key Points: 
  • Austin, Texas, Feb. 21, 2024 (GLOBE NEWSWIRE) -- Austin, TX– Experts at the Lady Bird Johnson Wildflower Center are predicting the 2024 wildflower season to be a banner year of blooms.
  • “Last summer’s drought likely helped this spring’s wildflower display,” added Matt O’Toole, Director of Land Management for the Wildflower Center.
  • For more information about the 2024 wildflower season, visit the Wildflower Center’s Texas Wildflower Central webpage.
  • To download high-resolution wildflower photos for your story, please visit this link and credit each photo as “Credit: Lady Bird Johnson Wildflower Center”.

Mandalay Resources Announces Financial Results for the Third Quarter 2023 and CFO Transition

Retrieved on: 
Thursday, November 9, 2023
Crown–Indigenous Relations and Northern Affairs Canada, CFO, Shepherd, EBITDA, Gold, Antimony, Lupinus, Costerfield, La Quebrada, Hardness, Maintenance, Printed circuit board, Internet service provider

Costerfield produced 8,377 ounces of gold and 395 tonnes of antimony for 10,808 gold equivalent ounces in the third quarter of 2023.

Key Points: 
  • Costerfield produced 8,377 ounces of gold and 395 tonnes of antimony for 10,808 gold equivalent ounces in the third quarter of 2023.
  • During Q3 2023, Costerfield generated $19.1 million in revenue and $7.7 million in adjusted EBITDA, which resulted in net income of $3.5 million.
  • Care and maintenance spending at Lupin was less than $0.1 million during the third quarter of 2023, which was same as in the third quarter of 2022.
  • Reclamation spending at Lupin was $0.1 million during the third quarter of 2023 compared to $1.2 million in the third quarter of 2022.

Mandalay Resources Announces Financial Results for the Third Quarter 2023 and CFO Transition

Retrieved on: 
Wednesday, November 8, 2023
Crown–Indigenous Relations and Northern Affairs Canada, CFO, Shepherd, EBITDA, Gold, Antimony, Lupinus, Costerfield, La Quebrada, Hardness, Maintenance, Printed circuit board, Internet service provider

Costerfield produced 8,377 ounces of gold and 395 tonnes of antimony for 10,808 gold equivalent ounces in the third quarter of 2023.

Key Points: 
  • Costerfield produced 8,377 ounces of gold and 395 tonnes of antimony for 10,808 gold equivalent ounces in the third quarter of 2023.
  • During Q3 2023, Costerfield generated $19.1 million in revenue and $7.7 million in adjusted EBITDA, which resulted in net income of $3.5 million.
  • Care and maintenance spending at Lupin was less than $0.1 million during the third quarter of 2023, which was same as in the third quarter of 2022.
  • Reclamation spending at Lupin was $0.1 million during the third quarter of 2023 compared to $1.2 million in the third quarter of 2022.

Lupin Collaborates with Mark Cuban Cost Plus Drug Company and COPD Foundation to Expand Access to Medication for COPD Patients

Retrieved on: 
Wednesday, September 6, 2023
COPD, Lupinus, Cost Plus Drugs, Chronic obstructive pulmonary disease, Health, Death, Patient, Tiotropium bromide, Boehringer Ingelheim, Pharmaceutical industry

NAPLES, Italy, Sept. 6, 2023 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) today forged a unique collaboration with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs), a pioneer in affordable medicines, and the COPD Foundation, dedicated to enhancing the lives of COPD patients.

Key Points: 
  • NAPLES, Italy, Sept. 6, 2023 /PRNewswire/ -- Global pharma major Lupin Limited (Lupin) today forged a unique collaboration with Mark Cuban Cost Plus Drug Company (Cost Plus Drugs), a pioneer in affordable medicines, and the COPD Foundation, dedicated to enhancing the lives of COPD patients.
  • Our collaboration with Mark Cuban Cost Plus Drug Company and the COPD Foundation reflects our intent to provide quality treatment options for patients."
  • "We are excited to work with Lupin and the COPD Foundation to bring lower prescription drug prices to consumers," said Alex Oshmyansky, CEO of Mark Cuban Cost Plus Drug Company.
  • "Cost Plus Drugs, Lupin and the COPD Foundation all share a common goal of providing consumers the lowest possible price for their prescription medication.

Olivut Resources Ltd. Announces Changes to The Board of Directors and Grant of Stock Options

Retrieved on: 
Wednesday, August 30, 2023
Giant, REE, Seahorse, TSX Venture Exchange, University, Statistics, KiMs, Bachelor of Science, Government, NWT, University of Victoria, Corporation, COVID-19, Collection, National instrument, Mining, Diamond, National Instrument 43-101, Giant Mine, Tundra, Rare-earth element, Lupinus

TORONTO, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Olivut Resources Ltd. (“Olivut” or the “Company”) (TSXV:OLV) is pleased to announce the addition of Mr. Kenny Ruptash to the Board of Directors of the Corporation.

Key Points: 
  • TORONTO, Aug. 30, 2023 (GLOBE NEWSWIRE) -- Olivut Resources Ltd. (“Olivut” or the “Company”) (TSXV:OLV) is pleased to announce the addition of Mr. Kenny Ruptash to the Board of Directors of the Corporation.
  • His extensive experience has given him a deeper understanding of northern Canada while providing insight into the challenges and opportunities associated with extremely remote mining operations.
  • He is a second-term director of the Business Development Investment Corporation, a government lending facility that supports businesses in the NWT.
  • His extensive experience will be a significant asset and the Olivut team looks forward to working with him.

North America Dominates Global Fibrate Drugs Market - Key Players and Developments Revealed - ResearchAndMarkets.com

Retrieved on: 
Thursday, August 17, 2023
Health, Pharmaceutical, Infection, Prevalence, Sun Pharma, Atrial fibrillation, Cholesterol, Stroke, COVID-19, Cardiovascular disease, Ageing, Fenofibrate, Compound annual growth rate, Lupinus, Incidence, Capsule, Risk, Blood, Dietary supplement, Pharmaceutical industry, Growth

The market is also witnessing the launch of various effective fibrate drugs by key market players.

Key Points: 
  • The market is also witnessing the launch of various effective fibrate drugs by key market players.
  • North America is expected to hold a significant market share in the global fibrate drugs market due to the high prevalence of the cardiovascular population and a rapidly aging population.
  • The presence of key market players and increasing product developments in North American countries are also contributing factors to market growth.
  • The fibrate drugs market is fragmented and competitive, with several major players dominating the market.

Lupin Launches Tiotropium Dry Powder for Inhaler for the Treatment of COPD in the United States

Retrieved on: 
Wednesday, August 16, 2023
Boehringer Ingelheim, COPD, Chronic obstructive pulmonary disease, Lupinus, FDA, Death, Patient, Tiotropium bromide, Pharmaceutical industry

BALTIMORE, Aug. 16, 2023 /PRNewswire/ -- Lupin Pharmaceuticals, Inc., the U.S. based wholly-owned subsidiary of global pharma major Lupin Limited (Lupin) today announced the launch of Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, for the treatment of chronic obstructive pulmonary disease (COPD) in the US.

Key Points: 
  • BALTIMORE, Aug. 16, 2023 /PRNewswire/ -- Lupin Pharmaceuticals, Inc., the U.S. based wholly-owned subsidiary of global pharma major Lupin Limited (Lupin) today announced the launch of Tiotropium Bromide Inhalation Powder, 18 mcg/capsule, for the treatment of chronic obstructive pulmonary disease (COPD) in the US.
  • Tiotropium Bromide Inhalation Powder, 18 mcg/capsule is a generic equivalent of Spiriva® HandiHaler® (Tiotropium Bromide Inhalation Powder), 18 mcg/capsule of Boehringer Ingelheim Pharmaceuticals, Inc.
    With this launch, Lupin introduces an alternative to combat COPD, a condition impacting over 15 million adults in the US and ranked as the fourth leading cause of death in the country.
  • By extending enhanced accessibility to cutting-edge products, Lupin actively contributes to alleviating the burden of COPD for patients across the nation.
  • "We are delighted to announce the launch of generic Spiriva® HandiHaler® in the US, the first generic to this important drug for COPD.

Is this the protein plant of the future? New study finds 'sweetness gene' that makes lupins tastier

Retrieved on: 
Friday, August 4, 2023
DNA, Human, Food, Industry, Biochemistry, Seed, Genetics, Alkaloid, Fungal infection, Mutation, Research, Plant, Animal, Gene, Canker, Genome, Legume, Medicinal plants, Vaccine, Mediterranean Sea, Lupinus

Lupins are very high in protein and fibre, low in carbs, have a low glycaemic index, and they’re easy to grow in a variety of climates.

Key Points: 
  • Lupins are very high in protein and fibre, low in carbs, have a low glycaemic index, and they’re easy to grow in a variety of climates.
  • The search for sweetness
    Around 100 years ago, plant breeders in Germany found natural mutations that produced “sweet lupins” with far lower levels of bitter alkaloids.
  • Over the past 50 years or so, lupins have become more common as food for farm animals.
  • Read more: Plant-based patties, lab-grown meat and insects: how the protein industry is innovating to meet demand

The 2nd Edition Corp Comm Summit & Awards by Transformance: Unveiling the Future of Corporate Communication

Retrieved on: 
Monday, July 31, 2023
Lead, Opus Media Partners, PwC, Communication, Corporate communication, Cision, RPG Group, Marketing, Amazon, Lupinus, Strategic management, Alvarez, Motivation, Alvarez and Marsal, Knowledge, Secrecy, Environment, Corporate title, Conference, PR, Management

The Conference is an unparalleled gathering of Top 100+ corporate communication professionals from cross industries, delivering a plethora of insights and inspiration to navigate the dynamic landscape of corporate communication successfully.

Key Points: 
  • The Conference is an unparalleled gathering of Top 100+ corporate communication professionals from cross industries, delivering a plethora of insights and inspiration to navigate the dynamic landscape of corporate communication successfully.
  • The Corp Comm Summit & Awards 2023 is a must-attend event for professionals seeking to stay ahead by aligning corporate communication to business strategy.
  • The 2nd Edition Corp Comm Summit & Awards will provide a unique platform to Unleash the Secret of Aligning Corporate Communications with Business Strategy.
  • The major highlights also comprises Awards where we recognize and celebrate the outstanding contributions of the corporate communications professionals.

The 2nd Edition Corp Comm Summit & Awards by Transformance: Unveiling the Future of Corporate Communication

Retrieved on: 
Monday, July 31, 2023
Lead, Opus Media Partners, PwC, Communication, Corporate communication, Cision, RPG Group, Marketing, Amazon, Lupinus, Strategic management, Alvarez, Motivation, Alvarez and Marsal, Knowledge, Secrecy, Environment, Corporate title, Conference, PR, Management

The Conference is an unparalleled gathering of Top 100+ corporate communication professionals from cross industries, delivering a plethora of insights and inspiration to navigate the dynamic landscape of corporate communication successfully.

Key Points: 
  • The Conference is an unparalleled gathering of Top 100+ corporate communication professionals from cross industries, delivering a plethora of insights and inspiration to navigate the dynamic landscape of corporate communication successfully.
  • The Corp Comm Summit & Awards 2023 is a must-attend event for professionals seeking to stay ahead by aligning corporate communication to business strategy.
  • The 2nd Edition Corp Comm Summit & Awards will provide a unique platform to Unleash the Secret of Aligning Corporate Communications with Business Strategy.
  • The major highlights also comprises Awards where we recognize and celebrate the outstanding contributions of the corporate communications professionals.